CINARVET PLUS (Cinnarizine (20mg) + Dimenhydrinate (40mg))

Cinarvet-Plus Tablet is formulated with a blend of antihistamine and antiemetic agents, primarily intended for the management of Meniere’s disease, which is a disorder affecting the inner ear. This condition can manifest symptoms such as vertigo, characterized by a sensation of spinning or dizziness, along with tinnitus, which refers to a ringing sound in the ears, nausea, vomiting, and potential hearing loss. Meniere’s disease occurs due to disturbances in the inner ear, leading to episodes of vertigo and associated auditory issues. The composition of Cinarvet-Plus includes ‘Cinnarizine,’ an antihistamine that mitigates the impacts of histamine—a chemical released during allergic reactions—within the brain. Cinnarizine also functions as a calcium channel blocker, enhancing blood flow within the inner ear and alleviating symptoms resulting from vertigo, tinnitus, and Meniere’s disease. Additionally, ‘Domperidone,’ an antiemetic agent, acts by blocking dopamine receptors in the brain that trigger nausea and vomiting. It promotes the movement and contractions of the stomach muscles, serving as a prokinetic agent helpful for controlling acid reflux. The prescribing physician will determine the appropriate dosage and treatment duration tailored to the individual’s condition severity. Although side effects may vary among patients, common reactions include drowsiness, nausea, dry mouth, indigestion, and weight gain. If any side effects become bothersome, it is advisable to seek medical advice. It is essential to inform your healthcare professional of any other medications you are taking, as well as any existing medical conditions such as liver, kidney, or heart disease, Parkinson’s disease, blood disorders, or allergies before initiating treatment with Cinarvet-Plus Tablet. Due to potential weight gain, a balanced diet should be emphasized. Consultation with a healthcare provider is recommended for pregnant or breastfeeding individuals.